fda ruling on compounded tirzepatide Judge says compounding pharmacies must stop making copies of Zepbound, Mounjaro Priority Meds Tirzepatide: Complete Review

A randomized clinical trial revealed that among overweight and obese participants with type 2 diabetes, subcutaneous liraglutide daily resulted in weight loss over 56 weeks compared to placebo

Authors reply to Peronard and Mayntz: SGLT2 inhibitors, and how they work beyond the glucosuric effect

9,10 GLP-1 receptor agonists (GLP-1RAs) are a class of drugs designed to mimic endogenous GLP-1 and bind to its receptors to promote glucose homeostasis in patients with T2D

On the other hand, aromatase inhibitors (AIs), like anastrozole, letrozole or exemestane, are used to treat post-menopausal women and men with ER-positive breast cancer

For patients building a comprehensive brain health stack, adding Better Vitality NAD+ provides mitochondrial and DNA repair support that complements the neural architecture work Dihexa is doing

FDA Regulation Semaglutide products are soaring in popularity